PHARMA MAR, S.A. «12345...» Página 3 de 11 desde 01/07/1988 hasta 24/05/2018 15/11/2017 08:12 PHARMA MAR, S.A. R&D: new licenses, patents and registered trademarks After analysis of the safety data of the first 150 patients, IDMC recommends that the Phase III trial with Zepsyre® in small-cell lung cancer patients should continue without any changes Número de registro: 258531 14/11/2017 08:09 PHARMA MAR, S.A. Announcements of public presentations and meetings Pharma Mar will participate in the Stifel Nicolaus Weisel Healthcare Conference to be held in New York on Nov. 15. Número de registro: 258469 08/11/2017 19:31 PHARMA MAR, S.A. R&D: new licenses, patents and registered trademarks Pharma Mar announces CHMP negative trend vote in relation to Aplidin Marketing Authorization Application for multiple myeloma. Número de registro: 258359 24/10/2017 17:49 PHARMA MAR, S.A. Information on P&L The Company sends press release regarding the third quarter 2017 results. Número de registro: 257730 24/10/2017 17:42 PHARMA MAR, S.A. Interim financial information La sociedad remite información sobre los resultados del tercer trimestre de 2017 Número de registro: 257728 11/10/2017 17:42 PHARMA MAR, S.A. Liquidity contracts and specialists The Company reports details of the operations of the Liquidity Agreement between 11/07/2017 and 10/10/2017 Número de registro: 257312 28/09/2017 18:18 PHARMA MAR, S.A. Liquidity contracts and specialists The Company reports on the adjustments of the balances in the securities and cash account associated with the liquidity agreement entered into with the entity Mediación Bursátil, Sociedad de Valores, S.A. Número de registro: 256845 19/09/2017 16:30 PHARMA MAR, S.A. R&D: new licenses, patents and registered trademarks Press release announcing the start of clinical development with a Pharma Mar´s new antitumor compound Número de registro: 256535 31/08/2017 12:04 PHARMA MAR, S.A. R&D: new licenses, patents and registered trademarks Press release on the forthcoming presentations of studies with Yondelis® and PM1183 to be held at the Congress of the European Society of Clinical Oncology. Número de registro: 256025 16/08/2017 17:41 PHARMA MAR, S.A. Liquidity contracts and specialists Modification of the cash account balance associated with the Liquidity Agreement. Número de registro: 255821 Página 3 de 11 «12345...»